These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22447484)

  • 1. Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.
    Huang JJ; Yu J; Li JY; Liu YT; Zhong RQ
    Med Oncol; 2012 Dec; 29(4):2402-8. PubMed ID: 22447484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma.
    Qu X; Zhao M; Wu S; Yu W; Xu J; Xu J; Li J; Chen L
    Med Oncol; 2014 Oct; 31(10):219. PubMed ID: 25216866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
    Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
    Hao M; Zang M; Wendlandt E; Xu Y; An G; Gong D; Li F; Qi F; Zhang Y; Yang Y; Zhan F; Qiu L
    Int J Cancer; 2015 Apr; 136(8):1835-44. PubMed ID: 25220540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.
    Jones CI; Zabolotskaya MV; King AJ; Stewart HJ; Horne GA; Chevassut TJ; Newbury SF
    Br J Cancer; 2012 Dec; 107(12):1987-96. PubMed ID: 23169280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.
    Hao M; Zang M; Zhao L; Deng S; Xu Y; Qi F; An G; Qin Y; Sui W; Li F; Yang W; Li Z; Yi S; Zou D; Zhan F; Qiu L
    Oncotarget; 2016 Apr; 7(15):19589-600. PubMed ID: 26995755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
    Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
    BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miR-16 and miR-21 Levels in Multiple Myeloma: Prognostic Significance of Survival and Response to Lenalidomide Treatment.
    Gkioka AI; Tsota M; Koudouna A; Gkiokas A; Mitropoulou CA; Palaiokrassa A; Alexandropoulos A; Papadatou-Gigante M; Bartzi V; Tryfou TM; Sfikakis PP; Dedoussis GV; Kyrtsonis MC
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
    Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Li J; Zhang M; Wang C
    J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
    Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
    Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma].
    Xu YN; Xiao CR; Huang YD; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):471-475. PubMed ID: 28446295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma.
    Jiang Y; Luan Y; Chang H; Chen G
    Oncol Lett; 2018 Sep; 16(3):4001-4007. PubMed ID: 30128020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma.
    Peng J; Thakur A; Zhang S; Dong Y; Wang X; Yuan R; Zhang K; Guo X
    Tumour Biol; 2015 Nov; 36(11):8545-52. PubMed ID: 26032093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
    Zhang ZY; Li YC; Geng CY; Zhou HX; Gao W; Chen WM
    Hematol Oncol; 2019 Oct; 37(4):409-417. PubMed ID: 31102419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
    Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
    Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.